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Melanocortins and agouti-related protein modulate the
excitability of two arcuate nucleus neuron populations by
alteration of resting potassium conductances
Mark A. Smith1, Kazunari Hisadome1, Hind Al-Qassab2, Helen Heffron2, Dominic J. Withers2
and Michael L. J. Ashford1
1Neurosciences Institute, Division of Pathology and Neuroscience, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK
2Centre for Diabetes and Endocrinology, Rayne Institute, University College London, London, UK
The hypothalamic melanocortin system is crucial for the control of appetite and body
weight. Two of the five melanocortin receptors, MC3R and MC4R are involved in
hypothalamic control of energy homeostasis, with the MC4R having the major influence.
It is generally thought that the main impact of the melanocortin system on hypothalamic
circuits is external to the arcuate nucleus, and that any effect locally in the arcuate
nucleus is inhibitory on proopiomelanocortin-expressing (POMC) neurons. In contrast, using
current- and voltage-clamp recordings from identified neurons, we demonstrate that MC3R and
MC4R agonists depolarize arcuate POMC neurons and a separate arcuate neuronal population
identified by the rat insulin 2 promoter (RIPCre) transgene expression. Furthermore, the
endogenous MC3R and MC4R antagonist, agouti-related protein (AgRP), hyperpolarizes POMC
and RIPCre neurons in the absence of melanocortin agonist, consistent with inverse agonism at
the MC4R. A decreased transient outward (I A) potassium conductance, and to a lesser extent
the inward rectifier (KIR) conductance, underlies neuronal depolarization, whereas an increase
in I A mediates AgRP-induced hyperpolarization. Accordingly, POMC and RIPCre neurons may
be targets for peptide transmitters that are possibly released locally from AgRP-expressing and
POMC neurons in the arcuate nucleus, adding further previously unappreciated complexity to
the arcuate system.
(Received 17 August 2006; accepted after revision 19 October 2006; first published online 26 October 2006)
Corresponding author M. Ashford: Division of Pathology and Neuroscience, Ninewells Hospital and Medical School,
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Over a billion people worldwide are overweight with 300
million classified as obese (Bays, 2004). Recent research
into the central regulation of energy homeostasis has
focused on a prototypical hypothalamic arcuate nucleus
(ARC) network (Cowley, 2003; Cone, 2005), containing
two neuronal populations, those expressing neuro-
peptide Y (NPY), and proopiomelanocortin (POMC).
NPY stimulates, and α-melanocyte-stimulating hormone
(α-MSH – a POMC gene product) suppresses, food
intake (Ramos et al. 2005). Agouti-related protein
(AgRP) is predominantly localized to NPY neurons,
is a natural antagonist of α-MSH on melanocortin 3
(MC3R) and melanocortin 4 (MC4R) receptors and
Re-use of this article is permitted in accordance with the creative
commons Deed, attribution 2.5, which does not permit commercial
exploitation.
stimulates a long-lasting increase in food intake (Hagan
et al. 2000). The NPY/AgRP and POMC systems alter
metabolic homeostasis by regulation of gene transcription,
excitability and synaptic transmission (Cowley, 2003;
Cone, 2005). They project to areas such as the
paraventricular nucleus (PVN) and lateral hypothalamic
area (LHA), where further integration occurs and outputs
from these and the ARC extend to extra-hypothalamic
centres. Hence, sites extrinsic to the ARC are thought to
be where melanocortin receptors predominantly influence
circuits responsible for energy homeostasis.
Alterations of the melanocortin pathway,
predominantly via the MC4R, have a major influence
on energy homeostasis. Global deletion of the NPY gene
(Erickson et al. 1996) produces a weak phenotype in
comparison to transgenes that target the melanocortin
system. Notably the MC4R knockout mouse (Huszar et al.
1997) and mice overexpressing agouti (Fan et al. 1997)
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or AgRP (Graham et al. 1997) are obese. Furthermore,
selective ablation of AgRP and POMC neurons induces
anorexia and hyperphagia, respectively, (Gropp et al.
2005). The MC4R displays constitutive activity, which
appears to be essential for body weight maintenance
(Srinivasan et al. 2004). AgRP is an inverse agonist
and suppresses the intrinsic activity of the MC4R
(Haskell-Luevano & Monck, 2001), indicating that AgRP
may increase food intake independently of melanocortin
ligands. Moreover, approximately 5% of severe human
obesity has been ascribed to MC4R deficiency (Farooqi
et al. 2000), and the melanocortin system, including
AgRP, is implicated in anorexia (Kas et al. 2003), cachexia
(Lechan & Tatro, 2001) and type 2 diabetes (Bonilla et al.
2006).
Although melanocortin receptors are key elements in
energy homeostasis control, relatively little is known
about the electrophysiological properties of MC3R- and
MC4R-expressing neurons in these hypothalamic circuits.
Previous studies have shown that ARC NPY neurons are
insensitive to the mixed MC3R and MC4R agonist, MTII
(Roseberry et al. 2004) and POMC neurons are inhibited
by an MC3R agonist (Cowley et al. 2001). In addition to
these neurons, an independent ARC neuronal population,
identified by the rat insulin 2 promoter (RIPCre)
transgene expression was demonstrated to differ from
POMC neurons in its response to insulin and leptin.
POMC neurons are hyperpolarized by insulin and
depolarized by leptin, whereas RIPCre neurons are
depolarized by insulin but are insensitive to leptin
(Choudhury et al. 2005). Additionally, the mixed
MC3R/MC4R agonist MTII depolarized RIPCre neurons.
Consequently, we have investigated the mechanisms
by which melanocortin agonists and AgRP alter the
excitability of POMC and RIPCre neurons. We show
here that melanocortin agonists depolarize and induce
excitation of both POMC and RIPCRe neurons and that
AgRP inhibits both neuron populations by membrane
hyperpolarization.
Methods
Hypothalamic slice preparation
As previously described (Choudhury et al. 2005), we
have used two Cre recombinase transgenic lines, RIPCre
and POMCCre and intercrossed these with the ZEG
indicator mouse to generate mice expressing green
fluorescent protein (GFP) in selective hypothalamic
neuronal populations. All procedures conformed to the
UK Animals (Scientific Procedures) Act 1986, and were
approved by our institutional ethical review committee.
RIPCreZEG and POMCCreZEG mice (8-16 weeks old)
were killed by cervical dislocation, the brain rapidly
removed and submerged in an ice-cold slicing solution
containing (mm): KCl 2.5, NaH2PO4 1.25, NaHCO3 28,
CaCl2 0.5, MgCl2 7, d-glucose 7, ascorbate 1, pyruvate 3
and sucrose 235, equilibrated with 95% O2–5% CO2 to
give a pH of 7.4. Hypothalamic coronal slices (350 µm),
containing the ARC, were cut using a Vibratome,
transferred and kept at room temperature (22–25◦C) in
an external solution containing (mm): NaCl 125, KCl 2.5,
NaH2PO4 1.25, NaHCO3 25, CaCl2 2, MgCl2 1, d-glucose
10, d-mannitol 15, ascorbate 1 and pyruvate 3, equilibrated
with 95% O2–5% CO2; pH 7.4, ∼320 mosmol l−1.
Electrophysiology
Individual arcuate neurons were identified by
epifluorescence and differential interference contrast
optics using an upright Zeiss Axioskop-2 FS plus micro-
scope. Slices were continually perfused with a modified
external solution (0.5 mm CaCl2 and 2.5 mm MgCl2, no
ascorbate and pyruvate) at a flow rate of 5–10 ml min−1
and a bath temperature of 33◦C. For experiments in
high-potassium solution, the normal external solution
was replaced by a solution containing (mm): NaCl 130,
KCl 20, CaCl2 0.5, MgCl2 2.5, d-glucose 10, d-mannitol
15 and Hepes 10; pH 7.4, ∼320 mosmol l−1. Patch-clamp
recordings were performed using borosilicate patch
pipettes (4–8 M) filled with an internal solution
containing (mm): potassium gluconate 130, KCl 10,
EGTA 0.5, Hepes 10, NaCl 1, CaCl2 0.28, MgCl2 3,
Na2ATP 3, Tris-GTP 0.3 and phosphocreatine 14; pH 7.2,
∼310 mosmol l−1. Whole-cell series resistance (Rs) was
compensated using an Axopatch 200B amplifier in
current- (I fast) and voltage-clamp modes (Rs, 30–60
and 10–30 M, respectively). Note that any remaining
uncompensated capacitance, produced by the voltage
steps, was digitally subtracted in Igor Pro using a −90 mV
voltage step as a template. Voltage and current commands
were manually or externally driven using pCLAMP 9.2
software and injected into neurons via the patch-clamp
amplifier. Under current clamp, hyperpolarizing current
pulses (5–20 pA, 200 ms, at a frequency of 0.05 Hz) were
used to monitor input and series resistance. Whole-cell
currents and voltages were filtered at 5 and 2 kHz,
respectively, and digitized at 50 kHz using pCLAMP
9.2 software. Miniature excitatory postsynaptic currents
(mEPSCs) were recorded in a standard external solution
(2 mm CaCl2 and 1 mm MgCl2) and in the presence of
(+)bicuculline (20 µm), whereas miniature inhibitory
postsynaptic currents (mIPSCs) were recorded in the
presence of 2 mm kynurenic acid. Neurons were voltage
clamped at −70 mV using a CsCl-based (130 mm)
internal solution containing 5 mm QX314 to block
regenerative sodium spikes. Unitary events of uniform
rise and decay kinetics were identified by the template
detection function in Clampex 9.2 and were analysed
for peak amplitude and frequency. All data were stored
unsampled on digital audio tape for off-line analysis
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using Clampex 9.2 or Igor Pro. Membrane potentials were
either replayed unsampled on an EasyGraph TA240 chart
recorder (Gould), or digitized and imported into Adobe
illustrator for illustration purposes.
Unless stated otherwise, drugs were added to the
external solution and applied to the slice via the perfusion
system. Occasionally, drugs were locally applied using
a broken-tipped pipette (∼4 µm diameter) positioned
above the recording neurons, as previously described
(Choudhury et al. 2005). At least 10 min of stable control
data were recorded before the application of any drug, and,
wherever possible, complete reversibility upon washout
was sought. However, some responses appeared not to
reverse completely as commonly found with peptides,
even following extensive washout (≥1 h). Note that
neuronal integrity was assessed by all of the following:
small holding current (≤20 pA at −70 mV) when voltage
clamped, high input resistance (≥1 G), large amplitude
rebound spikes, the ability to fire and lack of obvious
morphological deterioration (i.e. lack of blebbing and
nucleus not visually present).
Chemicals
Kynurenic acid, (+)bicuculline, tetraethylammonium
chloride (TEA), tolbutamide, 4-aminopyridine (4-AP),
nimodipine, QX314 and mibefradil dihydrochloride were
purchased from Sigma (Dorset, UK). Neuropeptide Y
(NPY), JKC363, SHU9119, AgRP (82–131)-amide, MC4R
agonist (cyclo(β-Ala-His-d-Phe-Arg-Trp-Glu)-NH2) and
melanotan II (MTII) were obtained from Phoenix
Pharmaceuticals Inc. (Belmont, CA, USA). Tetrodotoxin
(TTX), r-tertiapin-Q, r-heteropodatoxin-2 (HpTX) and
ω-conotoxin GVIA were purchased from Alomone
Laboratories Ltd (Jerusalem, Israel). d-Trp8-γ -MSH was
a gift from Dr V. J. Hruby (University of Arizona).
Statistics
Statistical significance was determined on all neurons
examined within a data set, using Student’s two-tailed
paired t test. However, as described by Cowley et al.
(2001), we found that POMC neuronal responsiveness
was not homogeneous. Therefore, as described by
Dhillon et al. (2006), we divided responding neurons
from non-responding neurons based on the criterion
that the change (in membrane potential or current
amplitude) induced by the drug challenge was ± three
times the standard deviation prior to drug addition. The
mean ± standard error of these responses is presented,
with the number of cells studied.
Results
Whole-cell current-clamp recordings were made from
GFP-positive hypothalamic arcuate neurons from
RIPCreZEG and POMCCreZEG mice. Consistent with
previous reports (Cowley et al. 2001; Acuna-Goycolea &
van den Pol, 2005; Choudhury et al. 2005; Plum et al.
2006), under control conditions, arcuate neurons were
characterized by high mean input resistances (RIPCre,
1.9 ± 0.2 G, n = 62; POMC, 1.5 ± 0.05 G, n = 50) and
spontaneously fired sodium-mediated action potentials
from a mean resting membrane potential (V m, range
−40 to −60 mV) of −50 ± 1 mV (RIPCre; n = 62) and
−50 ± 1 mV (POMC; n = 50).
Selective MC3R and MC4R agonists depolarize POMC
and RIPCre neurons
In contrast to a previous report (Cowley et al. 2001),
the selective MC3 receptor agonist (d-Trp8-γ -MSH,
10–50 nm) depolarized (P < 0.05, n = 11) POMC
neurons (Fig. 1A) by +5.9 ± 1.2 mV (n = 7 out of 11),
although a lower concentration (5 nm) had no effect on
POMC neuronal excitability (n = 5, data not shown).
d-Trp8-γ -MSH (10–20 nm) also depolarized RIPCre
neurons (Fig. 1B) by +9.6 ± 3.2 mV (P < 0.05, n = 5
out of 5). Moreover, the selective MC4 receptor agonist
cyclo(β-Ala-His-d-Phe-Arg-Trp-Glu)-NH2 (10–20 nm;
Bednarek et al. 2001) depolarized a majority of POMC
neurons (Fig. 1C, P < 0.05, n = 6) by +2.0 ± 0.4 mV
(n = 4 out of 6) and RIPCre neurons (Fig. 1D, P < 0.05,
n = 17) by +5.4 ± 1.2 mV (n = 7 out of 17).
AgRP and SHU9119 oppose the actions
of melanocortin agonists
As the response to the MC4R agonist was unexpected,
we examined whether AgRP could oppose the
constitutive receptor activity associated with this
receptor type (Haskell-Luevano & Monck, 2001). In
the absence of bath-applied melanocortin agonist and
consistent with its inverse agonist properties, AgRP
(10–20 nm) hyperpolarized RIPCre (change in V m
(V m), −18.3 ± 4.8 mV, P < 0.05, n = 4 out of 4) and
POMC (V m, −2.4 ± 0.7 mV, n = 5 out of 10; P < 0.05,
n = 10) neurons (Fig. 2A and B). However, AgRP did not
significantly affect input resistance (% of control: RIPCre,
78 ± 15%; POMC, 93 ± 7%; P > 0.1). Furthermore,
AgRP did not exert its neuromodulatory effects on these
ARC neurons indirectly by alteration of synaptic activity as
RIPCre neuron membrane potential was hyperpolarized
by AgRP (Fig. 2C; n = 3 out 3) in the presence of TTX
(0.5 µm).
We have previously shown that the mixed MC3R and
MC4R agonist, melanotan II (MTII) depolarizes RIPCre
neurons (Choudhury et al. 2005; Fig. 2D, n = 7 out
of 13). To confirm that MTII-induced depolarization
was due to the activation of MC3R and MC4R,
we attempted to block the MTII response by prior
application of the neutral MC3R and MC4R antagonist
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SHU9119. Accordingly, SHU9119 (10–25 nm) prevented
MTII-induced depolarization of RIPCre neurons
(SHU9119, −45 ± 4 mV; SHU9119 + MTII, −46 ± 3 mV;
n = 3 Fig. 2E) although, overall SHU9119 alone (P < 0.05,
n = 8) hyperpolarized (Fig. 2F) RIPCre neurons (V m,
−8.0 ± 2.8 mV, n = 5). MTII also depolarized POMC
neurons (P < 0.05, n = 11) by a similar magnitude to
RIPCre neurons (V m, +5.2 ± 1.1 mV, n = 5 out 11)
and this effect was prevented by SHU9119 (SHU9119,
−55 ± 3 mV; SHU9119 + MTII, −55 ± 3 mV; n = 5,
Fig. 2G). In contrast to SHU9119, application of the
selective MC4R antagonist JKC363 (10–20 nm) had no
effect on the membrane potential of RIPCre neurons,
but did reverse the depolarization (P < 0.05, n = 10)
induced by the selective MC4R agonist (Fig. 2H). The
MC4 receptor agonist depolarized RIPCre neurons by
+4.4 ± 1.6 mV (P < 0.05, n = 10) and the subsequent
application of JKC363, in the continuous presence
of MC4R agonist, repolarized these neurons by
−4.4 ± 1.6 mV (P < 0.05), although again a significant
delay in reversibility was observed (20–80 min). These
data suggest that SHU9119 may possess some intrinsic
inverse agonist activity independent of MC4R.
MTII and AgRP directly modulate POMC and RIPCre
neuronal activity
While the effects of MTII (Choudhury et al. 2005) and
AgRP were reproducible in the presence of TTX, it
is possible that spontaneous miniature synaptic events
(that are insensitive to TTX; Roseberry et al. 2004)
are modulated by these peptides and contribute to
the responses. Thus, the frequency and amplitude of
Figure 1. Selective MC3R and MC4R
agonists depolarize POMC and RIPCre
neurons
Current-clamp recordings were made from
POMC (A and C) and RIPCre (B and D) neurons
in the absence and presence of a selective
MC3R (10 nM D-Trp8-γ -MSH; A and B) or MC4R
(10 nM cyclo(β-Ala-His-D-Phe-Arg-Trp-Glu)-NH2;
C and D) agonist. MC3R or MC4R activation
results in POMC and RIPCre neuron
depolarization, as demonstrated by the
expanded sections shown underneath this and
subsequent figures. Note that the large
reversible depolarization induced by the MC3R
agonist (A) produces significant spike amplitude
attenuation.
spontaneous mIPSCs and mEPSCs were recorded in the
absence and presence of bath and/or locally applied
MTII. The frequencies of these spontaneous events
were not affected by 100 nm MTII in RIPCre (mIPSC:
control, 0.6 ± 0.2 Hz; MTII, 0.4 ± 0.1 Hz; n = 4, Fig. 3A;
mEPSC: control, 4.1 ± 1.3 Hz; MTII, 4.1 ± 1.2 Hz; n = 5,
Fig. 3B) and POMC (mIPSC: control, 0.5 ± 0.1 Hz; MTII,
0.7 ± 0.1 Hz; n = 5, Fig. 3E; mEPSC: control, 0.9 ± 0.2 Hz;
MTII, 0.4 ± 0.1 Hz; n = 5, Fig. 3F) neurons. Moreover,
the cumulative frequency–amplitude distributions did
not differ between control events and those recorded
in the presence of MTII for mEPSCs or mIPSCs in
RIPCre neurons (Fig. 3C and D) or for mEPSCs in POMC
neurons (Fig. 3G). However, in POMC neurons, mIPSC
amplitude was reversibly increased by MTII (change
in amplitude, +6.1 ± 0.9 pA, n = 5, P < 0.05) and the
cumulative frequency distribution shifted in the presence
of MTII (Fig. 3H). These data indicate that MTII increases
GABAA receptor tone on POMC neurons, as previously
reported (Cowley et al. 2001). In contrast, the mechanism
of action appears to differ, such that d-Trp8-γ -MSH was
reported to increase mIPSC frequency (Cowley et al. 2001),
whereas in this study MTII increased synaptic amplitude.
To provide additional evidence for a direct (i.e. non-
synaptic) effect of MTII and AgRP, the signalling pathway
between receptor and ion channel was blocked in the
postsynaptic neuron. Melanocortin receptors are members
of the G-protein-coupled receptor family and have been
reported to couple in a stimulatory manner to cAMP
(Wikberg, 1999). Thus, we examined the effect of an
inhibitor of cAMP-mediated outputs (Rp-cAMP) on
electrical actions of both MTII and AgRP on RIPCre
and POMC neurons. Neither the membrane potential
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Figure 2. AgRP and melanocortin (MC) receptor antagonists oppose or block the actions of MC receptor
agonists
RIPCre (A) and POMC (B) neurons are hyperpolarized by 10 nM AgRP, applied as denoted above the traces. C, AgRP
hyperpolarizes RIPCre neurons in the presence of 0.5 µM TTX. RIPCre and POMC neurons are depolarized by the
mixed MC3R/MC4R agonist MTII (100 nM; D and G) and this action is prevented by prior application of SHU9119
(20 nM; E and G). F, the majority of RIPCre neurons respond to SHU9119 alone by hyperpolarization. H, a selective
MC4R agonist (20 nM) depolarizes RIPCre neurons, an action that is reversed by the presence of a selective MC4R
receptor antagonist (20 nM, JKC363).
C© 2007 The Authors. Journal compilation C© 2007 The Physiological Society
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nor the spike frequency was altered by application of
100 nm MTII (control, −46 ± 2 mV; MTII, −45 ± 2 mV;
control, 4.3 ± 1.5 Hz; MTII, 4.5 ± 1.0 Hz, n = 6 out of 6)
or 10 nm AgRP (control, −47 ± 2 mV; AgRP, −46 ± 3 mV;
control, 2.9 ± 0.8 Hz; AgRP, 3.0 ± 0.4 Hz, n = 6 out of
6) when 100 µm Rp-cAMP was present in the recording
pipette solution (data not shown), suggesting that MTII
has a direct effect on these neurons via MC3 and MC4
receptors coupling to adenylate cyclase.
Block of K+ channels prevents MTII depolarization
As both POMC and RIPCre neurons displayed
responses to melanocortin-selective ligands, which were
indistinguishable from one another qualitatively, we
did not discriminate between these populations when
examining the mechanisms underlying these electrical
changes, and consequently utilized MTII as agonist.
Initially, we attempted to block the depolarizing response
of MTII by the presence, in the bath solution, of various
heavy metal cations (0.1–1 mm Gd3+, La3+, Cs+, Cd2+
or Ni2+), which block various non-selective cation and
Figure 3. Effects of MTII on
spontaneous synaptic events
RIPCre (A–D) and POMC (E–H) neurons were
voltage clamped at −70 mV using a
CsCl-based internal solution. Miniature
excitatory (A and E) postsynaptic currents
(mEPSC) were recorded in the presence of
20 µM (+)bicuculline, whereas miniature
inhibitory postsynaptic currents (mIPSC;
B and F) were recorded in the presence of
2 mM kynurenic acid. Under these recording
conditions, both inhibitory and excitatory
currents are shown as downward
deflections, as demonstrated by the
representative traces shown in A, B, E and F.
Note that co-application of (+)bicuculline
and kynurenic acid blocked all synaptic
events (data not shown). Synaptic currents
were recorded in the absence (left) and
presence (right) of 100 nM MTII, as
indicated. Superimposed synaptic events are
shown underneath in grey and composite
traces from between 50 and 150 events are
shown in black. Representative amplitude–
cumulative frequency histograms from
recordings shown above are shown for
mEPSC and mIPSC in RIPCre (C and D,
respectively) and POMC (G and H,
respectively) neurons.
calcium channels (Hille, 2001). However, these and
indeed more selective calcium channel blockers such
as ω-conotoxin GVIA (100 nm), nimodipine (10 µm)
and mibefradil (10 µm) did not alter the membrane
potential or prevent MTII-induced depolarization of
RIPCre neurons (data not shown). These data, while
not conclusive, indicate that calcium and non-selective
cation conductances are unlikely to be responsible for the
MTII-induced depolarization. Thus, we assessed whether
blocking potassium conductance could mimic or prevent
the depolarization elicited by MTII on ARC neurons.
The presence of the ATP-sensitive potassium (KATP)
channel inhibitor tolbutamide (200 µm) did not
significantly affect membrane potential and failed to
prevent depolarization of RIPCre neurons by 100 nm
MTII (n = 3 out of 3; data not shown). Ba2+ (100 µm),
a non-selective inward rectifier potassium (KIR) channel
blocker (Takano & Ashcroft, 1996; Liu et al. 2001), induced
a small depolarization of RIPCre and POMC neurons
(Fig. 4A) by +2.5 ± 0.5 mV (n = 4 out of 4, P < 0.05).
The voltage-dependent transient outward potassium
(‘IA-type’ currents) channel blocker (Wang et al. 1996),
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4-AP (4 mm) depolarized RIPCre and POMC neurons
by +5.6 ± 0.5 mV (P < 0.05, n = 5 out of 5; Fig. 4B).
These actions of Ba2+ and 4-AP were reproducible in the
presence of inhibitors of glutamatergic (kynurenic acid)
and GABAergic ((+)bicuculline) fast neurotransmission
(data not shown). Consequently, hyperpolarizing current
was injected into neurons in the presence of either
Ba2+ or 4-AP to reset the membrane potential to the
preblocker value prior to challenge with MTII (see Fig. 4B
and C). Subsequent application of 100 nm MTII, in the
presence of either Ba2+ (control, −52 ± 2 mV; Ba2+,
−52 ± 2 mV; n = 4 out of 4) or 4-AP (control, −57 ±
4 mV; 4-AP, −58 ± 6 mV; n = 4 out of 4) alone did not
affect the resting membrane potential (Fig. 4A and B).
Although Ba2+ was difficult to wash out from the slice,
on the occasions where clear reversibility was obtained,
re-application of 100 nm MTII induced a depolarizing
response (e.g. Fig. 4A). Thus, the presence of either
Ba2+ or 4-AP alone is capable of preventing neuron
depolarization by 100 nm MTII, although MTII increased
spike frequency from control by 69 ± 20% (n = 4,
P < 0.05) and 36 ± 5% (n = 4, P < 0.05) in the presence
of 4-AP and Ba2+, respectively (Fig. 4A and B). However,
in the combined presence of Ba2+ and 4-AP, 100 nm MTII
was unable to alter the membrane potential (control,
−55 ± 2 mV; MTII, −55 ± 4 mV, n = 5 out of 5) or firing
frequency (control, 3.4 ± 0.5 Hz; MTII, 3.6 ± 0.7 Hz,
n = 5) of POMC neurons (Fig. 4C), suggesting that both
conductances (the transient outward current (henceforth
termed IA for convenience) and KIR) contribute to the
MTII response.
MTII and AgRP have opposing actions
on K+ conductances
In order to identify the potassium conductance modulated
by MTII and AgRP, RIPCre neurons were voltage
clamped in an external solution containing 10 µm
bicuculline, 2 mm kynurenic acid and 1 µm TTX to
block synaptic transmission and regenerative Na+ spikes.
Neurons were held at −70 mV and voltage pulses
(500 ms duration) were stepped from −90 to −10 mV
in 5 mV increments, with a 5 ms prepulse stepped to
−170 mV (5 ms duration) to deactivate voltage-dependent
potassium conductances (Fig. 5A). Initial studies with an
external calcium concentration of 0.5 mm, 40 mm external
tetraethylammonium (TEA) and internal K+ replaced
by Cs+ (in order to inhibit potassium conductance),
demonstrated that no significant calcium current could
be observed (data not shown). In contrast, with
normal external saline and potassium gluconate in the
electrode solution, depolarizing command potentials
(above −45 mV) elicited outward current, characterized
by an initial rapid transient component that inactivated
to reveal an underlying steady-state current (Fig. 5B).
Figure 4. Ba2+ and 4-AP occlude MTII depolarization of RIPCre
and POMC neurons
A, representative current-clamp recording from an RIPCre neuron
showing that application of 100 µM Ba2+ prevents 100 nM
MTII-induced depolarization, although there was an increase in firing
frequency (as shown in the expanded sections underneath). Washout
of the Ba2+ allowed recovery of the MTII-induced depolarizing
response, with significant spike amplitude attenuation. > represents
continuity of the voltage trace. B, 4 mM 4-AP caused depolarization of
RIPCre neurons. Following injection of current (Iinj.) to restore the
membrane potential, MTII was unable to induce significant
depolarization, though firing frequency was increased. C, combined
application of Ba2+ (100 µM) and 4-AP (4 mM) resulted in neuron
(POMC) depolarization and on subsequent restoration of the
membrane potential by current injection; application of MTII had no
effect on membrane potential or firing frequency.
C© 2007 The Authors. Journal compilation C© 2007 The Physiological Society
432 M. A. Smith and others J Physiol 578.2
Such current kinetics are indicative of the IA and delayed
rectifier (IK) potassium conductances, respectively. To
confirm this interpretation we examined the effect of the
IA channel blocker 4-AP (4 mm). Accordingly, at −10 mV,
4-AP blocked the peak current by 56 ± 6% (P < 0.05,
n = 4 out of 4) but also partially blocked the steady-state
(measured at the end of the pulse) current (Fig. 5B) by
28 ± 6% (P < 0.05, n = 4 out of 4). Application of 40 mm
Figure 5. The transient voltage-gated potassium (IA) conductance is modulated by MTII in RIPCre and
POMC neurons
RIPCre (B–E and G–J) and POMC (F) neurons were voltage clamped and K+ currents elicited following the pulse
protocol shown in A. The 5 ms prepulse to −170 mV was used to deactivate any voltage-dependent potassium
conductance. B, representative currents elicited by a −10 (upper traces; inset) and −15 mV (lower traces) voltage
step in the absence (red) and presence of bath applied 4-AP (4 mM, blue). C, representative current families in
the absence and presence of locally applied MTII (100 nM). D and E, MTII reversibly decreased the peak current,
shown for expanded single test pulses to −20 mV (D) and with respect to time (E). Control currents are shown
in blue, MTII in red, washout in black (D) and correspond to the time points displayed by these colours in E.
F, representative currents elicited by a −20 mV voltage step in the absence (blue) and presence (red) of locally
applied MTII (100 nM). G, control currents in the absence (left) and presence (right) of 100 nM r-heteropodatoxin-2
(HpTX). H, isolated IA currents are shown in the absence (left) and presence of MTII (right), following subtraction
of the IK conductance isolated by HpTX (G, right). I, IA currents evoked at −20 mV are shown following 5 s
prepulses from −100 to −40 mV (10 mV increments). Note currents following the −40 mV prepulse were used
to subtract the underlying IK conductance. J, plots of voltage against the mean ratio of conductance (G) and
maximum conductance (Gmax) for each current in the absence (black symbols) and presence (red symbols) of MTII.
Activation (squares) and steady-state inactivation (circles) curves shown were best fitted to the Boltzmann function
and indicate the presence of a small window current that peaks at approximately −50 mV.
TEA resulted in a 68 ± 4% (n = 4 out of 4, P < 0.05)
depression in the amplitude of the delayed rectifier current
(data not shown).
Local application of MTII above the recorded neuron
depressed IA peak amplitude at all voltages where a
significant outward current could be observed (Fig. 5C).
This is more clearly shown for single currents elicited by
depolarization to −20 mV, where 100 nm MTII reduces
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IA peak amplitude, an action that is reversible and can
be replicated by further application of MTII (Fig. 5D
and E). Thus, at a test potential of −20 mV, MTII
decreased IA peak amplitude in RIPCre (P < 0.05, n = 8)
neurons by 11 ± 5% (n = 7 out of 8) and in POMC
(P < 0.05, n = 8) neurons by 10 ± 2% (n = 5 out of 8;
Fig. 5F). These data indicate that MTII preferentially
modulates the 4-AP-sensitive, voltage-dependent
transient conductance IA in both RIPCre and POMC
neurons. To examine the mechanisms of action in more
detail, we isolated IK pharmacologically by removing
IA with a specific Kv4.2 toxin HpTX (100 nm, Tang
et al. 2005; Fig. 5G and H , n = 3) or used a −40 mV
prepulse to inactivate IA (Fig. 5I , n = 4). Following
the subtraction of IK from the original current traces,
the underlying IA conductance was obtained (Fig. 5H
and I). Although local application of MTII reduced
the magnitude of IA (P = 0.05, n = 13) by 23 ± 3%
(n = 7 out 13), transient inactivation was not affected (at
−20 mV, the inactivation time constants were 23 ± 6 ms
in control versus 26 ± 7 ms in the presence of 100 nm
MTII, n = 7). Modulation of the voltage-dependent
activation and steady-state inactivation kinetics of IA
are possible mechanisms to explain the actions of MTII.
Thus, voltage was plotted against the ratio of the IA
conductance (G) at each voltage and the maximum IA
conductance (Gmax) and curves fitted to the Boltzmann
function (Fig. 5J). However, the voltage-dependent
activation and steady-state inactivation curves were not
altered by MTII, in cells where IA was reduced, with
half-maximum activation (V 0.5) potentials of −31 ± 1
and −32 ± 1 mV (n = 7) for control and 100 nm MTII,
respectively, and half-maximum inactivation (V 0.5) values
of −65 ± 2 and −64 ± 2 mV (n = 4) for control and
in the presence of 100 nm MTII, respectively. Note the
presence of a small IA window current, which peaks at
approximately −50 mV (Fig. 5J) and encompasses the
range of membrane potentials observed in this study. This
is consistent with IA participating in the control of the
resting membrane potential.
In contrast with MTII, local application of 10 nm AgRP
to voltage-clamped RIPCre neurons caused an increase
in IA amplitude (P < 0.05, n = 9) at all potentials where
this current was visible (Fig. 6A). This action of AgRP was
not immediately reversed on washout (Fig. 6B and C). For
example, at a potential of −15 mV, AgRP increased peak
amplitude by 19 ± 7% (n = 7 out of 9). Although on some
occasions AgRP apparently increased the current through
IK (Fig. 6A), this was not a consistent finding and, on
average, there was no significant effect on the steady-state
outward current amplitude in the presence of either MTII
or AgRP. As with MTII, the voltage-dependent activation
curve of IA was not affected by AgRP such that V 0.5 values
were unaltered (control, −31 ± 1 mV; AgRP, −32 ± 1 mV,
n = 7; Fig. 6D). These data suggest that MTII and AgRP
modulate IA independent of changes in voltage-dependent
gating.
As previously described for POMC neurons (Roseberry
et al. 2004), we found that the KIR conductance in
RIPCre arcuate neurons was extremely small (0.3 ± 0.1 nS,
n = 9) under our recording conditions where the KATP
channels were mostly closed. To increase the magnitude of
the inward rectifier potassium conductance, the external
potassium concentration was raised from 2.5 to 20 mm and
RIPCre neurons were voltage clamped at −70 mV with 1 s
voltage ramps from −170 to +30 mV used to assess the
KIR conductance. As a result of the relative linearization
of the potassium gradient and the shift in the reversal
potential (predictions from the Nernst equation are −106
and −51 mV for 2.5 and 20 mm [K+]o, respectively), the
linear slope conductance (measured between −130 and
Figure 6. AgRP enhances the transient voltage-gated potassium
conductance in RIPCre neurons
A, representative current families in the absence and presence of
locally applied AgRP (10 nM). B and C, AgRP increased peak current
amplitude, which was partially reversed on washout, shown for
expanded single test pulses to −20 mV (B) and with respect to time
(C). Control currents are shown in blue, AgRP in red, washout in black
(B) and correspond to the time points displayed by these colours in C.
D, plot of voltage against the mean ratio of conductance (G) and
maximum conductance (Gmax) for each current in the absence (black
squares) and presence (red circles) of AgRP. Curves shown are the data
best fitted to the Boltzmann function.
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−50 mV) in 20 mm [K+]o was 1.57 ± 0.23 nS (n = 23).
A pronounced inward rectification close to the predicted
reversal potentials was seen (Fig. 7A). In agreement with
a previous study on arcuate neurons (Roseberry et al.
2004), this resting KIR conductance was blocked by 100 µm
external Ba2+, which induced a 66 ± 10% (P < 0.05;
n = 5 out of 5) reduction (Fig. 7A and B). In contrast,
a much smaller proportion of KIR was blocked by 200 µm
tolbutamide, although this did not reach significance
at the 95% level with a 26 ± 21% (P = 0.09, n = 5 out
of 5) reduction in KIR (Fig. 7B). It is surprising that
application of the high affinity G-protein-coupled inward
rectifier potassium (GIRK; Kir3 family) channel inhibitor
(Kanjhan et al. 2005; Acuna-Goycolea & van den Pol,
2005) r-tertiapin-Q toxin (100 nm) had no significant
effect (Fig. 7C) on the KIR conductance (92 ± 6% of
control, P = 0.3; n = 5) suggesting lack of resting GIRK
channel activity under non-stimulatory conditions. Local
application of 100 nm MTII had no effect on the linear
slope conductance of KIR (P > 0.1, n = 26), although
in a minority population (n = 10 out of 26), a small
(5.5 ± 2.0%) reversible decrease in current was observed
(Fig. 7D). Likewise, KIR slope conductance was not affected
following the application of 10 nm AgRP (101 ± 4% of
control, P > 0.7, n = 13, Fig. 7E).
We next assessed the actions of selective MC3 and
MC4 receptor agonists on these potassium currents.
We were concerned that the small changes we expected
in IA amplitude could be affected by errors that
occur when trying to voltage clamp large amplitude
currents. Therefore, to obviate this problem, we monitored
both IA and KIR in the high (20 mm) [K+]o solution,
such that the shift in the predicted reversal potential
increases inward (below −51 mV) and decreases outward
(above −51 mV) potassium currents. Local application
of the MC3R selective agonist 10 nm d-Trp8-γ -MSH
reduced the peak amplitudes of IA (P < 0.05, n = 12,
Fig. 7F), as did the MC4R selective agonist, 10 nm
(cyclo(β-Ala-His-d-Phe-Arg-Trp-Glu)-NH2) (P < 0.05,
n = 14, Fig. 7I). Thus, at a test voltage of −15 mV, IA
peak amplitude was decreased by 8 ± 3% (n = 8 out
of 12) and 12 ± 3% (n = 7 out of 14) in the presence
of the MC3 (Fig. 7G) and MC4 (Fig. 7J) receptor agonists,
respectively. Furthermore, the selective MC3R (P < 0.05,
n = 12) and MC4R (P = 0.07, n = 14) agonists decreased
KIR currents (Fig. 7F and I), although the latter response
was not significant at the 95% level of confidence.
For RIPCre neurons that produced a response to these
agonists, the steady-state slope conductance (measured
at the end of each voltage step between −90 and
−50 mV) was decreased by 18 ± 5% (n = 8 out 12)
and 28 ± 8% (n = 7 out of 14) by application of the
MC3 (Fig. 7H) and MC4 (Fig. 7K) receptor agonists,
respectively. These data indicate that both melanocortin
receptor subtypes contribute to melanocortin agonist
modulation of IA and perhaps KIR conductances in ARC
neurons.
Discussion
Melanocortin-driven excitation and inhibition
of identified arcuate neurons
Previous studies demonstrate a wide CNS distribution of
MC3R and MC4R, with moderate MC3R and low MC4R
density in the arcuate (Mountjoy et al. 1994; Harrold et al.
1999; Liu et al. 2003). The PVN and dorsomedial nucleus
(DMH) express much higher levels of MC4R (Liu et al.
2003) and are the hypothalamic areas with the greatest
sensitivity to melanocortin agonists and AgRP (Kim et al.
2000). The location and effectiveness of MC4R modulation
in hypothalamic circuits is particularly important given
that MC4R knockout mice display a more severe obese
phenotype (Huszar et al. 1997) than MC3R knockout mice
(Butler et al. 2000). Moreover, AgRP and MTII do not
significantly affect food intake or body weight in MC4R
knockout mice (Fekete et al. 2004). It is interesting that
using a Cre-mediated reactivation approach, Balthasar
et al. 2005) showed that MC4R outside the PVN and
amygdala is required to replicate the phenotype of the
MC4R global null mouse. Clearly, MC4R is crucial for
energy homeostasis, but questions remain as to the cellular
mechanisms by which melanocortin agonists and AgRP
modulate hypothalamic neuron excitability and the role
of these receptors in the ARC.
We have demonstrated that two distinct arcuate neuron
populations, POMC and RIPCre, display sensitivity to
MC3R and MC4R selective agonists and to the inverse
agonist, AgRP. A previous study on POMC neurons
reported that the selective MC3R agonist d-Trp8-γ -MSH
hyperpolarized the majority of POMC neurons, although
it was unclear whether this was due to indirect (MC3R
autoreceptor) or direct action (Cowley et al. 2001). As
we had previously reported that the mixed MC3R/MC4R
agonist MTII depolarized RIPCre neurons (Choudhury
et al. 2005), we expected the MC4R agonist to depolarize
these arcuate neurons. However, MC3R and MC4R
agonists depolarize both POMC and RIPCre neurons,
and MTII induces depolarization in the presence of TTX.
Furthermore, we found no evidence of altered synaptic
drive (inhibitory or excitatory), causing a change of
membrane potential, or of direct hyperpolarization of
POMC neurons. These results are consistent with a recent
report that MTII depolarizes MC4R-positive neurons in
the DMH/PVN (Liu et al. 2003). Nevertheless, we observed
that MTII drives a small increase in mIPSC amplitude
in POMC neurons, indicating that under specific ionic
conditions, MTII could hyperpolarize POMC neurons
via an indirect, presynaptic mechanism. However, MTII
failed to hyperpolarize POMC or RIPCre neurons under
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Figure 7. Melanocortin agonists modulate both KIR and IA
A, inward rectifying potassium conductance was monitored in voltage clamped RIPCre neurons by application of a
1 s voltage ramp (as shown). Increasing the potassium concentration from 2.5 to 20 mM increases the linear slope
conductance and shifts the reversal potential to positive potentials. Note the pronounced inward rectification at
the predicted Nernst potentials (2.5 mM [K+]o, −106 mV; 20 mM [K+]o, −51 mV). B and C, this inwardly rectifying
potassium conductance was blocked by 100 µM Ba2+ (red traces in A and B), partly blocked by 200 µM tolbutamide
(B, blue trace) but not by 100 nM r-tertiapin-Q toxin (C, red trace). D and E, local application of 100 nM MTII
(D, red trace) reversibly (D, blue trace) decreased this current, although 10 nM AgRP had no affect (E, red trace).
F, representative current families in the absence and presence of 10 nM MC3R agonist. G, the MC3 agonist
decreased the peak IA current, shown for expanded single test pulses to −15 mV. H, current–voltage relationships
for steady-state current (measured at the end of the trace in F) in the absence (black squares) and presence
(red circles) of the MC3 agonist. I, representative current families in the absence and presence of 10 nM MC4R
agonist. J, the MC4 agonist decreased the peak IA current, shown for expanded single test pulses to −10 mV. K,
current–voltage relationships for steady-state current (measured at the end of the traces in I) in the absence (black
squares) and presence (red circles) of the MC4 agonist.
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control conditions or when the MC receptor signalling
system in the postsynaptic neuron was blocked with
Rp-cAMP. Following dialysis of the neuron with our
internal recording solution (chloride reversal potential is
−53 mV), an increase in GABAA activity is unlikely to have
much influence on membrane potential (V m, −50 mV).
Using the perforated-patch technique, which does not
disrupt the intracellular environment, we observed
similar MTII-induced depolarizations. Increasing mIPSC
amplitude could reduce input resistance and shunt the
resting potassium conductance, which would result in
depolarization. However, no significant change in input
resistance was observed in this study, perhaps due to
the combination of opening GABAA channels, inhibition
of resting potassium conductances, and opening of
voltage-gated conductances that accompany neuronal
depolarization.
Does MC4R constitutive activity contribute
to neuron excitability?
The MC4R displays constitutive activity in the absence of
ligand, which is inhibited by AgRP binding (Nijenhuis
et al. 2001). The long-term increase in food intake induced
by AgRP administration may be a result of its inverse
agonist properties because JKC363 (a selective MC4R
antagonist) does not replicate this action (Kim et al.
2002). POMC and RIPCre neuronal hyperpolarization by
AgRP in the absence of exogenously applied melanocortin
agonist is consistent with inverse agonism, whereby
the intrinsic activity of the receptor contributes a tonic
depolarizing influence. Alternative explanations for
the hyperpolarization are that AgRP acts on a separate
(non-melanocortin) receptor (Hagan et al. 2000; Kim
et al. 2002) or behaves as a competitive antagonist at
MC3R and MC4R (Yang et al. 1999) to block the actions of
endogenously released α-MSH. The latter possibility,
although supported by the observation that SHU9119
causes RIPCre neuron hyperpolarization, is not
substantiated by the lack of effect of JKC363, and the
finding that AgRP induces hyperpolarization in the
presence of TTX.
Mechanisms of melanocortin and AgRP actions
on POMC and RIPCre neurons
The K+ channel blocker data indicate that reduced
postsynaptic potassium conductance underlies the
depolarization elicited by melanocortin agonists. Voltage-
clamp recordings from arcuate neurons demonstrate
that melanocortin agonists reduced IA and, to a lesser
extent, KIR conductances. Indeed, to completely inhibit
the depolarizing/excitatory influence of MTII on RIPCre
and POMC neurons required the simultaneous presence of
inhibitors of these conductances, 4-AP (IA) and Ba2+ (KIR).
This supports the notion that multiple K+ conductances
control the excitability of arcuate neurons. Previous studies
have suggested that GIRK channels underlie the resting
potassium conductance in POMC neurons (Cowley et al.
2001; Ibrahim et al. 2003; Roseberry et al. 2004). However,
the concentrations (> 100 µm) of barium used to sub-
stantiate this claim block most of the KIR family. Indeed,
the GIRK channel inhibitor r-tertiapin-Q toxin did not
block the resting inward rectifier conductance in this,
and a recent (Acuna-Goycolea & van den Pol, 2005),
study indicating that another strong inward rectifier (e.g.
KIR2 family) may underlie this conductance. The finding
that melanocortin agonists, and AgRP, alter IA in POMC
and RIPCre neurons indicates that this conductance is a
common target for transmitter receptors in hypothalamic
neurons (Burdakov & Ashcroft 2002; Tang et al. 2005).
The mechanism by which melanocortin receptors alter
IA is unclear. We have no evidence for modulation of
voltage-dependent gating to explain the modification of IA
and suggest that a change in channel open state probability
or availability may be responsible.
Arcuate neurons have high input resistances (1–2 G)
as a result of a very low resting conductance, thus a
change of a few picoamps in resting KIR and/or IA
window current is more than sufficient to produce
millivolt changes in V m. Additionally, because these
neurons have a membrane potential that straddles the
threshold for action potential firing, such modest changes
in conductance and membrane potential can have a
significant effect on spike frequency. A recent report
shows that although NPY and peptide YY (PYY3-36)
inhibited resting calcium conductances in POMC and
NPY neurons, this did not affect membrane potential
(Acuna-Goycolea & van den Pol, 2005). However, NPY,
PYY3-36 and µ-opioid receptor stimulation activate a
GIRK, r-tertiapin-Q toxin-sensitive (Acuna-Goycolea &
van den Pol, 2005) conductance in identified arcuate
neurons (Cowley et al. 2001; Ibrahim et al. 2003; Roseberry
et al. 2004). This causes significant hyperpolarization
with a large increase in resting potassium conductance.
Consequently, to repolarize arcuate neurons when GIRK
channels are activated, significant neuronal excitation or
the closure of GIRK channels is required. Such responses
are quite distinct from melanocortin receptor agonist
actions described here, which use alternative conductances
(IA and KIR) to produce modest changes in membrane
potential (∼5 mV) and resting conductance (∼20% of
control), and perhaps are best described as neuro-
modulatory rather than having the ability to turn neurons
‘on’ or ‘off’.
Implications for the local arcuate circuit model
The presence of functional MC4R and MC3R on POMC
neurons suggests that both could amplify melanocortin
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peptide release, in a local arcuate positive feedback circuit.
In contrast, AgRP acting on POMC neurons would inhibit
this positive feedback loop, by antagonism of MC3R
and through inverse agonism at MC4R, and provide
local inhibition of the melanocortin network even in
the absence of significant α-MSH release. This would
reinforce orexigenic outputs and limit satiety signals at
the level of the arcuate circuitry in addition to AgRP
limiting melanocortin signals at second-order neurons
in the PVN and LHA. The functional activation of
melanocortin receptors on RIPCre neurons suggest that
this neuronal type may also integrate the gene products
locally released from both POMC- and AgRP-expressing
neurons. Therefore, we suggest that the two-neuron model
of ARC circuitry involved in control of energy homeostasis
(Cowley et al. 2001; Cowley, 2003; Cone, 2005) may need
to be extended in order to encompass additional neuronal
types such as RIPCre.
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